Welcome to LookChem.com Sign In|Join Free

CAS

  • or

40523-32-8

Post Buying Request

40523-32-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

40523-32-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 40523-32-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,5,2 and 3 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 40523-32:
(7*4)+(6*0)+(5*5)+(4*2)+(3*3)+(2*3)+(1*2)=78
78 % 10 = 8
So 40523-32-8 is a valid CAS Registry Number.

40523-32-8Relevant articles and documents

SET photochemistry of phthalimide anion and its reactivity with hydrogen donors

Sánchez-Sánchez, Cristobal,Pérez-Inestrosa, Ezequiel,García-Segura, Rafael,Suau, Rafael

, p. 7267 - 7274 (2002)

The investigation of the photochemistry of phthalimide anion has uncovered its exceptional reactivity with hydrogen donors such as alcohols, toluene, ethers and amines. Photoreactions can be conducted to high conversions and photoadducts are formed in high yield and with predictable regioselectivity. Exploratory studies have revealed that SET from the excited phthalimide anion to phthalimide is a thermodinamically favourable step that produces the electrophilic phthalimidyl radical and is the key step of the process.

Copper-mediated oxidative C-H/N-H activations with alkynes by removable hydrazides

Ackermann, Lutz,Gu, Linghui,Li, Bo,Ma, Wenbo,Mei, Ruhuai,Xiong, Feng,Yang, Chenrui,Zou, Liang

supporting information, p. 1591 - 1599 (2021/07/26)

The efficient copper-mediated oxidative C-H alkynylation of benzhydrazides was accomplished with terminal alkynes. Thus, a heteroaromatic removable N-2-pyridylhydrazide allowed for domino C-H/N-H functionalization. The approach featured remarkable functional group compatibility and ample substrate scope. Thereby, highly functionalized aromatic and heteroaromatic isoindolin-1-ones were accessed with high efficacy with rate-limiting C-H cleavage.

Phenylidene phenyl peptide compounds and medicinal composition and application thereof

-

Paragraph 0148-0152, (2018/11/22)

The invention provides phenylidene phenyl peptide compounds, a medicinal composition using the phenylidene phenyl peptide compounds as active components, and application thereof as monoamine oxidase B(MAO-B) inhibitors and application thereof to preparation of medicines for treating Parkinson's disease (PD). Monoamine oxidase B (MAO-B) has been proved to be closely related to the pathogenesis ofthe Parkinson's disease (PD) and is a classic target for research and development of the medicines for treating the Parkinson's disease (PD). The invention provides application of the phenylidene phenyl peptide compounds to preparation of the monoamine oxidase B (MAO-B) inhibitors. In-vitro kinase activity experiments prove that the phenylidene phenyl peptide compounds have a significant monoamineoxidase B (MAO-B) inhibiting effect.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 40523-32-8